Gregory R. Cox

58 year

Health Technology

Consumer Services

Profile

Gregory R.
Cox worked as Treasurer & Vice President at Corixa Corp.
from 1995 to 2005.
He then worked as Chief Financial Officer, Treasurer & Executive VP at Dendreon Corp.
from 2005 to 2015.
In 2015, he briefly served as Chief Financial Officer & Treasurer at Dendreon Corp.
Cox received his undergraduate degree from Otterbein College.

Former positions of Gregory R. Cox

Companies	Position	End
DENDREON CORPORATION	Director of Finance/CFO	2015-06-09
DENDREON CORPORATION	Director of Finance/CFO	2015-02-22
Corixa Corp. Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT.	Treasurer	2005-08-31

See the detail of Gregory R. Cox's experience

Training of Gregory R. Cox

Otterbein College

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gregory R. Cox's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Corixa Corp. Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT.	Health Technology
Dendreon Corp. Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA.	Health Technology